COPENHAGEN, Aug 9 (Reuters) - Danish industrial enzymes
maker Novozymes NZYMb.CO on Wednesday reported a
second-quarter operating profit below expectations and narrowed
the range for its full-year sales growth guidance to 4-6% from
4-7%.
Earnings before interest and tax fell to 865 million crowns
($127.4 million) from a year-earlier 1.11 billion, against a 965
million average expectation by analysts in a poll published by
the company.
($1 = 6.7881 Danish crowns)
(Reporting by Johannes Birkebaek, editing by Anna Ringstrom)
((Johannes.Birkebaek@thomsonreuters.com;))